[Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]
- PMID: 10774259
- DOI: 10.1248/yakushi1947.120.4_374
[Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]
Abstract
Macrolide antibiotics (Mac) consist of a 12- to 16-membered lactone ring combined with a sugar moiety, and they inhibit protein synthesis via binding to 23S ribosomal RNA in bacteria. The 14- and 16-membered Mac are used for treating infectious diseases caused by Gram-positive and other bacteria; e.g., Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila, Campylobacter, Treponema pallidum and Mycoplasma. Resistance to macrolide, lincosamide, and streptogramin-B (MLS) antibiotics in staphylococci is known to have the following mechanisms: 1) alteration of the target on ribosome due to dimethylation of a specific adenine residue in the 23S ribosomal RNA by the product of the erm gene, and consequently a decrease in binding of MLS antibiotics; 2) inactivation of streptogramin-B (STG-B) and lincosamide by the products of the sbh (encoding streptogramin B hydrolase) and linA' (encoding 3-lincomycin 4-clindamycin O-nucleotidyltransferase) genes, respectively; and 3) active efflux of Mac and STG-B antibiotics determined by the msrA and msrB genes in Staphylococcus epidermidis and Staphylococcus xylosus, respectively, both of which appear to act as an ATP-dependent efflux pump. I have shown that Staphylococcus aureus 8325(pEP2104) exhibits inducible resistance to PMS (partial macrolide and streptogramin B)-antibiotics [the 14-membered macrolides, erythromycin (EM), and oleandomycin (OL), and the 16-membered macrolide mycinamicin (MCM) and STG-B]. The sequence of the N-terminal amino acid residues of a 63 kDa protein (MsrSA) that appeared in the membrane of PMS-resistant strains was identical to that of an MsrA polypeptide related to enhanced efflux of [14C]EM. Ribosomes from PMS-resistant strains showed a similar affinity for EM to those from the PMS-sensitive host strain NCTC8325, and no inactivation of EM by 8325(pEP2104) was observed. In the present study, I showed the DNA sequence of the msrSA region on the constitutive PMS-resistant plasmid pMC38, PMS-inducible resistant plasmid pEP2104 and PMS-sensitive mutant plasmid pSP6, and the region that is essential for inducible expression in PMS resistance. In addition, I investigated the relationship between PMS resistance and intracellular accumulation of EM.
Similar articles
-
A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary.Biol Pharm Bull. 1995 Nov;18(11):1482-6. doi: 10.1248/bpb.18.1482. Biol Pharm Bull. 1995. PMID: 8593463
-
Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics.J Pharmacobiodyn. 1992 Jun;15(6):319-24. doi: 10.1248/bpb1978.15.319. J Pharmacobiodyn. 1992. PMID: 1432570
-
A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus.FEMS Microbiol Lett. 1997 Mar 1;148(1):91-6. doi: 10.1111/j.1574-6968.1997.tb10272.x. FEMS Microbiol Lett. 1997. PMID: 9066116
-
Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.J Antimicrob Chemother. 1987 Dec;20(6):783-802. doi: 10.1093/jac/20.6.783. J Antimicrob Chemother. 1987. PMID: 3326871 Review.
-
[Resistance to macrolides].Nihon Rinsho. 1997 May;55(5):1238-44. Nihon Rinsho. 1997. PMID: 9155181 Review. Japanese.
Cited by
-
Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus.Front Microbiol. 2021 Nov 4;12:760255. doi: 10.3389/fmicb.2021.760255. eCollection 2021. Front Microbiol. 2021. PMID: 34803985 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases